| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Dec―02 |
Abstract A64: Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2 |
Chrysovalantis Voutouri, Corey C Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin J. Khandekar, Justin F Gainor, et al. (+3) Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain |
| 2 |
[GO] |
2022―Jan―24 |
Immune-guided therapy of COVID-19 |
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, et al. (+2) Stefania Canè, Vincenzo Bronte |
| 3 |
[GO] |
2022―Jan―04 |
Abstract IA07: Impact of immunotherapy on COVID-19 immunity: Insights from checkpoint blockade in cancer |
Paulina Coutifaris, Kevin Wang, Sokratis Apostolidis, Mark Painter, Ahron Flowers, Rishi Goel, et al. (+11) Divij Mathew, Ajinkya Pattekar, Ravi Amaravadi, Tara Mitchell, Paul Bates, Scott Hensley, Giorgos Karakousis, Lynn Schuchter, Allie Greenplate, E. John Wherry, Alexander C. Huang |
| 4 |
[GO] |
2022―Jan―04 |
Abstract IA08: Adaptive immune dysregulation in cancer patients with SARS-CoV-2 infection |
Santosha A. Vardhana |
| 5 |
[GO] |
2022―Jan―04 |
Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity |
Mia Han, Jack Y. Lee, Vincent Wu, Kurt Sakurada, Bianca Nguyen, David A. Canton, Christopher G. Twitty |
| 6 |
[GO] |
2021―Jan―15 |
At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer |
Antoni Ribas, Marina Chiara Garassino |
|
